Skip to main content
SpringerLink
Log in

Benefits of antineoplastics not correlated with drug costs

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. 2016 US dollars

Reference

  • Becker DJ, et al. Exploration of the ASCO and ESMO Value Frameworks for Antineoplastic Drugs. Journal of Oncology Practice : JOP2016020339, 11 May 2017. Available from: URL: http://doi.org/10.1200/JOP.2016.020339

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Benefits of antineoplastics not correlated with drug costs. PharmacoEcon Outcomes News 779, 8 (2017). https://doi.org/10.1007/s40274-017-4023-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-017-4023-7

Search

Navigation